220 related articles for article (PubMed ID: 23465968)
1. Staging of gastroenteropancreatic neuroendocrine tumors: how we do it based on an evidence-based approach.
McDermott S; O'Neill AC; Skehan SJ
Clin Imaging; 2013; 37(2):194-200. PubMed ID: 23465968
[TBL] [Abstract][Full Text] [Related]
2. Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters.
Niederle MB; Hackl M; Kaserer K; Niederle B
Endocr Relat Cancer; 2010 Dec; 17(4):909-18. PubMed ID: 20702725
[TBL] [Abstract][Full Text] [Related]
3. Gastroenteropancreatic neuroendocrine tumors (GEP-NETs): a closer look at the characteristics of these diverse tumors.
Pape UF
Clin Adv Hematol Oncol; 2014 Dec; 12(12 Suppl 19):8-11. PubMed ID: 25768103
[No Abstract] [Full Text] [Related]
4. Pathological characteristics and clinical specifications in gastroenteropancreatic neuroendocrine tumors: a study of 68 cases.
Stoica-Mustafa E; Pechianu C; Iorgescu A; Hortopan M; Dima SO; Tomulescu V; Dumitraşcu T; Ungureanu C; Andronesi D; Popescu I; Herlea V
Rom J Morphol Embryol; 2012; 53(2):351-5. PubMed ID: 22732805
[TBL] [Abstract][Full Text] [Related]
5. Introduction to a revised clinicopathological classification of neuroendocrine tumors of the gastroenteropancreatic tract.
Rindi G; Capella C; Solcia E
Q J Nucl Med; 2000 Mar; 44(1):13-21. PubMed ID: 10932598
[TBL] [Abstract][Full Text] [Related]
6. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors.
Pape UF; Jann H; Müller-Nordhorn J; Bockelbrink A; Berndt U; Willich SN; Koch M; Röcken C; Rindi G; Wiedenmann B
Cancer; 2008 Jul; 113(2):256-65. PubMed ID: 18506737
[TBL] [Abstract][Full Text] [Related]
7. Gastroenteropancreatic neuroendocrine tumors in children and young adults.
Khanna G; O'Dorisio SM; Menda Y; Kirby P; Kao S; Sato Y
Pediatr Radiol; 2008 Mar; 38(3):251-9, quiz 358-9. PubMed ID: 17906857
[TBL] [Abstract][Full Text] [Related]
8. Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms.
Klöppel G
Endocr Relat Cancer; 2011 Oct; 18 Suppl 1():S1-16. PubMed ID: 22005112
[TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine tumors of the digestive tract: impact of new classifications and new agents on therapeutic approaches.
Oberg K
Curr Opin Oncol; 2012 Jul; 24(4):433-40. PubMed ID: 22510940
[TBL] [Abstract][Full Text] [Related]
10. Gastroenteropancreatic high-grade neuroendocrine carcinoma.
Sorbye H; Strosberg J; Baudin E; Klimstra DS; Yao JC
Cancer; 2014 Sep; 120(18):2814-23. PubMed ID: 24771552
[TBL] [Abstract][Full Text] [Related]
11. Neuroendocrine neoplasms of the gastroenteropancreatic system: pathology and classification.
Anlauf M
Horm Metab Res; 2011 Nov; 43(12):825-31. PubMed ID: 22105474
[TBL] [Abstract][Full Text] [Related]
12. Treatment of metastatic disease in patients with neuroendocrine tumors.
Niederhuber JE; Fojo T
Surg Oncol Clin N Am; 2006 Jul; 15(3):511-33, viii. PubMed ID: 16882495
[TBL] [Abstract][Full Text] [Related]
13. Improving survival prognostication of gastroenteropancreatic neuroendocrine neoplasms: Revised staging criteria.
Martin JA; Warner RR; Wisnivesky JP; Kim MK
Eur J Cancer; 2017 May; 76():197-204. PubMed ID: 28334622
[TBL] [Abstract][Full Text] [Related]
14. Sporadically occurring functional pancreatic endocrine tumors: review of recent literature.
Goldin SB; Aston J; Wahi MM
Curr Opin Oncol; 2008 Jan; 20(1):25-33. PubMed ID: 18043253
[TBL] [Abstract][Full Text] [Related]
15. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification.
Klöppel G; Couvelard A; Perren A; Komminoth P; McNicol AM; Nilsson O; Scarpa A; Scoazec JY; Wiedenmann B; Papotti M; Rindi G; Plöckinger U; ;
Neuroendocrinology; 2009; 90(2):162-6. PubMed ID: 19060454
[No Abstract] [Full Text] [Related]
16. [Morphological imaging of gastroenteropancreatic neuroendocrine tumours].
Camera L; Bresciani M; Soscia E; Percopo V; Mainenti PP; Salvatore M
Minerva Endocrinol; 2001 Sep; 26(3):123-8. PubMed ID: 11753234
[TBL] [Abstract][Full Text] [Related]
17. Correlation between grade and prognosis in metastatic gastroenteropancreatic neuroendocrine tumors.
Strosberg J; Nasir A; Coppola D; Wick M; Kvols L
Hum Pathol; 2009 Sep; 40(9):1262-8. PubMed ID: 19368957
[TBL] [Abstract][Full Text] [Related]
18. Circulating biomarkers in neuroendocrine tumors of the enteropancreatic tract: application to diagnosis, monitoring disease, and as prognostic indicators.
Ardill JE; O'Dorisio TM
Endocrinol Metab Clin North Am; 2010 Dec; 39(4):777-90. PubMed ID: 21095544
[TBL] [Abstract][Full Text] [Related]
19. [The new classification of neuroendocrine tumors from the clinical viewpoint].
Schürmann G; Senninger H
Z Gastroenterol; 1996 Jun; 34(6):402-3. PubMed ID: 8767831
[No Abstract] [Full Text] [Related]
20. Surgery for gastroenteropancreatic neuroendocrine tumors (GEPNETS).
Boudreaux JP
Endocrinol Metab Clin North Am; 2011 Mar; 40(1):163-71, ix. PubMed ID: 21349417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
